급성 창상관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Acute Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care), By Application (Surgical & Traumatic Wounds, Burns), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

급성 창상관리 시장 성장과 동향

세계 급성 창상관리 시장 규모는 2030년 119억 6,000만 달러에 달할 것으로 예상되며, 2025-2030년까지 연평균 4.3%의 성장률을 보일 것으로 전망됩니다.

화상 발병 사례의 증가, 전 세계 노인 인구의 증가, 외상성 사고 사례의 증가가 시장의 주요 촉진요인이 될 것으로 예상됩니다.

전 세계적으로 다양한 화상 사례가 증가하면서 시장 성장에 기여하고 있습니다. 예를 들어, ImpactLaw에 따르면, 전체 화학적 화상 사례 중 22,000건이 산에 노출되어 발생한 것으로 나타났습니다. 마찬가지로 알칼리성 용액에 노출되어 발생한 화상도 5만 5,500건에 달합니다. 또한, NCBI에 따르면 매일 약 3만 명이 화상을 입는 것으로 추정되며, 연간 약 1,100만 명이 화상을 입는 것으로 추정됩니다. 화상 치료에는 고급 상처 드레싱과 같은 급성 창상관리 제품이 사용됩니다. 따라서 화상 발생 건수의 증가가 시장을 견인할 것으로 예상됩니다.

또한 찰과상, 찢어짐, 교통사고, 폭행 등 외상성 사고가 증가하고 있습니다. 예를 들어, NCBI 통계에 따르면 찰과상은 유아의 가장 흔한 부상 형태이며 전체 부상의 70.7%를 차지합니다. 마찬가지로 미국 노동부 노동 통계국에 따르면 2020년 민간 산업에서 보고된 비 치명적 부상은 270만 건에 달했습니다. 또한 Brady United에 따르면 매년 약 117,345명이 총격으로 인해 급성 부상을 입는다고 합니다. 위의 요인으로 인해 급성 상처가 증가함에 따라 시장은 예측 기간 동안 성장할 것으로 예상됩니다.

COVID-19의 대유행으로 인해 시장 규모가 소폭 감소했습니다. 그러나 백신이 출시되고 잠금장치를 쉽게 사용할 수 있게 됨에 따라 팬데믹 이후에도 시장은 성장할 것으로 예상됩니다. 이러한 배경에는 재택 의료 시스템의 개선과 함께 주요 시장 참여자들의 다양한 전략적 노력이 있습니다. 예를 들어, 2022년 1월 ConvaTec Group PLC는 Triad Life Sciences Inc.와 정식 계약을 체결했습니다. 이 계약에 따르면 ConvaTec은 Triad Life Sciences Inc.를 인수하여 고급 상처 관리 사업을 강화할 것입니다.

급성 창상관리 시장 보고서 하이라이트

• 제품별로는 첨단 상처 드레싱 재료가 2024년 34.9% 이상의 가장 큰 매출 점유율을 차지했습니다. 이는 전 세계 사고 건수 증가에 기인합니다.
• 용도별로는 수술 및 외상성 상처 부문이 2024년 80.1% 이상의 점유율을 차지하며 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다.
• 최종 용도별로는 병원 부문이 2024년 시장을 장악했습니다. 재택 의료는 예측 기간 동안 가장 빠른 성장률을 기록할 것으로 예상됩니다.
• 북미는 2024년 시장을 장악했습니다. 아시아태평양은 외상성 사고의 증가와 노인 인구의 증가로 인해 예측 기간 동안 가장 빠른 성장률을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 급성 창상관리 시장 변수, 동향, 범위

• 시장 소개/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 급성 창상관리 시장 분석 툴
  • Porters 분석
  • PESTEL 분석

제4장 급성 창상관리 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 급성 창상관리 시장 : 제품 변동 분석, 2024년과 2030년
• 첨단 창상 피복재
• 외과적 창상관리
• 전통적 창상관리
• 창상관리 기기

제5장 급성 창상관리 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 급성 창상관리 시장 : 최종 용도 변동 분석, 2024년과 2030년
• 병원
• 전문 클리닉
• 재택의료

제6장 급성 창상관리 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 급성 창상관리 시장 : 용도 변동 분석, 2023년과 2030년
• 외과적 창상과 외상
• 화상

제7장 급성 창상관리 시장 : 지역별, 추정·동향 분석

• 급성 창상관리 시장 점유율, 지역별, 2024년과 2030년, 100만 달러
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 상황

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • 3M
  • Coloplast Corp
  • Smith+Nephew
  • Medtronic
  • ConvaTec Group PLC
  • Integra LifeSciences
  • Ethicon(Johnson & Johnson)
  • Baxter
  • Molnlycke Health Care AB

ksm

영문 목차

영문목차

Acute Wound Care Market Growth & Trends:

The global acute wound care market size is expected to reach USD 11.96 billion in 2030 and is projected to grow at a CAGR of 4.3% from 2025 to 2030. A rise in burn incidence cases, an increase in the global geriatric population, and rising cases of traumatic accidents are expected to be the key driving factors for the market.

The global rise in various burn cases is contributing to the growth of the market. For instance, according to ImpactLaw, out of total chemical burn cases, 22,000 cases are due to exposure to acid. Similarly, 55,500 burn cases can be accredited to exposure to alkaline solutions. Moreover, as per the NCBI, each day, an estimated 30,000 people suffer from burn injuries, whereas, it is predicted that annually, approximately 11 million people suffer due to burn incidents. Acute wound care products such as advanced wound dressing are used to treat burn marks. Thus, rising burn incidences are expected to drive the market.

Furthermore, the number of traumatic incidences such as abrasion, lacerations, road accidents, and assaults is growing. For instance, according to stats by the NCBI, abrasions are the most common form of injury in children accounting for 70.7% of all injuries. Similarly, as per the Bureau of Labor Statistics, U.S. Department of Labor, 2.7 million non-fatal injuries were reported by private industry labor in 2020. Moreover, according to Brady United, every year, around 117,345 people are shot down leading to acute wounds. As there has been a rise in acute wounds due to the above-mentioned factors, the market is anticipated to grow over the forecast period.

The COVID-19 pandemic resulted in a minor decrease in the market size. However, with the availability of vaccines and ease of lockdown, the market is expected to grow during the post-pandemic period. This can be attributed to various strategic initiatives by major market players, along with improvements in the home healthcare system. For instance, in January 2022, ConvaTec Group PLC entered into a definitive agreement with Triad Life Sciences Inc. According to this agreement, ConvaTec will acquire Triad Life Sciences Inc. in order to strengthen its advanced wound care business.

Acute Wound Care Market Report Highlights:

• On the basis of product, advanced wound dressing captured the largest revenue share of over 34.9% in 2024. This can be attributed to a rise in the number of accident cases globally
• Based on application, the surgical and traumatic wounds segment dominated the market with a share of over 80.1% in 2024 and is projected to witness the fastest growth over the forecast period
• On the basis of end-use, the hospitals segment dominated the market in 2024. Home healthcare is estimated to register the fastest growth rate over the forecast period
• North America dominated the market in 2024. Asia Pacific is anticipated to register the fastest growth rate over the forecast period owing to a rise in traumatic accidents and the growing geriatric population in this region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Acute Wound Care Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Acute Wound Care Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Acute Wound Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Acute Wound Care Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Advanced Wound Dressing
  • 4.3.1. Advanced Wound Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.1. Foam Dressings
      • 4.3.1.1.1. Foam Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.2. Hydrocolloid Dressings
      • 4.3.1.2.1. Hydrocolloid Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.3. Film Dressings
      • 4.3.1.3.1. Film Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.4. Alginate Dressings
      • 4.3.1.4.1. Alginate Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.5. Hydrogel Dressings
      • 4.3.1.5.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.6. Collagen Dressings
      • 4.3.1.6.1. Collagen Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Surgical Wound Care
  • 4.4.1. Surgical Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.1. Sutures & Staples
      • 4.4.1.1.1. Sutures & Staples Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2. Tissue Adhesives and Sealants
      • 4.4.1.2.1. Tissue Adhesives and Sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.3. Anti-infective Dressing
      • 4.4.1.3.1. Anti-infective Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Traditional Wound Care
  • 4.5.1. Traditional Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1. Medical Tapes
      • 4.5.1.1.1. Medical Tapes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2. Cleansing Agents
      • 4.5.1.2.1. Cleansing Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.3. Others
      • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Wound Therapy Devices
  • 4.6.1. Wound Therapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.1. Negative Pressure Wound Therapy
      • 4.6.1.1.1. Negative Pressure Wound Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.2. Oxygen and Hyperbaric Oxygen Equipment
      • 4.6.1.2.1. Oxygen and Hyperbaric Oxygen Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.3. Electric Stimulation Devices
      • 4.6.1.3.1. Electric Stimulation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.4. Pressure Relief Devices
      • 4.6.1.4.1. Pressure Relief Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.5. Others
      • 4.6.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Acute Wound Care Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Acute Wound Care Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Specialty Clinics
  • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Home Healthcare
  • 5.5.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Acute Wound Care Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Acute Wound Care Market: Application Movement Analysis, 2023 & 2030 (USD Million)
• 6.3. Surgical & Traumatic Wound
  • 6.3.1. Surgical & Traumatic Wound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Burns
  • 6.4.1. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Acute Wound Care Market: Regional Estimates & Trend Analysis

• 7.1. Acute Wound Care Market Share, By Region, 2024 & 2030, USD Million
• 7.2. North America
  • 7.2.1. North America Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1 Key Country Dynamics
    • 7.2.2.2 Regulatory Framework/Reimbursement Structure
    • 7.2.2.3 Competitive Scenario
    • 7.2.2.4. U.S. Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1 Key Country Dynamics
    • 7.2.3.2 Regulatory Framework/Reimbursement Structure
    • 7.2.3.3 Competitive Scenario
    • 7.2.3.4. Canada Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1 Key Country Dynamics
    • 7.2.4.2 Regulatory Framework/Reimbursement Structure
    • 7.2.4.3 Competitive Scenario
    • 7.2.4.4. Mexico Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1 Key Country Dynamics
    • 7.3.2.2 Regulatory Framework/Reimbursement Structure
    • 7.3.2.3 Competitive Scenario
    • 7.3.2.4. UK Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1 Key Country Dynamics
    • 7.3.3.2 Regulatory Framework/Reimbursement Structure
    • 7.3.3.3 Competitive Scenario
    • 7.3.3.4. Germany Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1 Key Country Dynamics
    • 7.3.4.2 Regulatory Framework/Reimbursement Structure
    • 7.3.4.3 Competitive Scenario
    • 7.3.4.4. France Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1 Key Country Dynamics
    • 7.3.5.2 Regulatory Framework/Reimbursement Structure
    • 7.3.5.3 Competitive Scenario
    • 7.3.5.4. Italy Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1 Key Country Dynamics
    • 7.3.6.2 Regulatory Framework/Reimbursement Structure
    • 7.3.6.3 Competitive Scenario
    • 7.3.6.4. Spain Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1 Key Country Dynamics
    • 7.3.7.2 Regulatory Framework/Reimbursement Structure
    • 7.3.7.3 Competitive Scenario
    • 7.3.7.4. Denmark Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1 Key Country Dynamics
    • 7.3.8.2 Regulatory Framework/Reimbursement Structure
    • 7.3.8.3 Competitive Scenario
    • 7.3.8.4. Sweden Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1 Key Country Dynamics
    • 7.3.9.2 Regulatory Framework/Reimbursement Structure
    • 7.3.9.3 Competitive Scenario
    • 7.3.9.4. Norway Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1 Key Country Dynamics
    • 7.4.2.2 Regulatory Framework/Reimbursement Structure
    • 7.4.2.3 Competitive Scenario
    • 7.4.2.4. Japan Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1 Key Country Dynamics
    • 7.4.3.2 Regulatory Framework/Reimbursement Structure
    • 7.4.3.3 Competitive Scenario
    • 7.4.3.4. China Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1 Key Country Dynamics
    • 7.4.4.2 Regulatory Framework/Reimbursement Structure
    • 7.4.4.3 Competitive Scenario
    • 7.4.4.4. India Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1 Key Country Dynamics
    • 7.4.5.2 Regulatory Framework/Reimbursement Structure
    • 7.4.5.3 Competitive Scenario
    • 7.4.5.4. Australia Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. South Korea
    • 7.4.6.1 Key Country Dynamics
    • 7.4.6.2 Regulatory Framework/Reimbursement Structure
    • 7.4.6.3 Competitive Scenario
    • 7.4.6.4. South Korea Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1 Key Country Dynamics
    • 7.4.7.2 Regulatory Framework/Reimbursement Structure
    • 7.4.7.3 Competitive Scenario
    • 7.4.7.4. Canada Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Regulatory Framework/Reimbursement Structure
    • 7.5.2.3 Competitive Scenario
    • 7.5.2.4. Brazil Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Regulatory Framework/Reimbursement Structure
    • 7.5.3.3 Competitive Scenario
    • 7.5.3.4. Argentina Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.6. Middle East and Africa
  • 7.6.1. Middle East and Africa Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1 Key Country Dynamics
    • 7.6.2.2 Regulatory Framework/Reimbursement Structure
    • 7.6.2.3 Competitive Scenario
    • 7.6.2.4. South Africa Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1 Key Country Dynamics
    • 7.6.3.2 Regulatory Framework/Reimbursement Structure
    • 7.6.3.3 Competitive Scenario
    • 7.6.3.4. Saudi Arabia Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1 Key Country Dynamics
    • 7.6.4.2 Regulatory Framework/Reimbursement Structure
    • 7.6.4.3 Competitive Scenario
    • 7.6.4.4. UAE Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1 Key Country Dynamics
    • 7.6.5.2 Regulatory Framework/Reimbursement Structure
    • 7.6.5.3 Competitive Scenario
    • 7.6.5.4. Kuwait Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles
  • 8.4.1. 3M
    • 8.4.1.1. Participant's Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Recent Developments/ Strategic Initiatives
  • 8.4.2. Coloplast Corp
    • 8.4.2.1. Participant's Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Recent Developments/ Strategic Initiatives
  • 8.4.3. Smith + Nephew
    • 8.4.3.1. Participant's Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Recent Developments/ Strategic Initiatives
  • 8.4.4. Medtronic
    • 8.4.4.1. Participant's Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Recent Developments/ Strategic Initiatives
  • 8.4.5. ConvaTec Group PLC
    • 8.4.5.1. Participant's Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Recent Developments/ Strategic Initiatives
  • 8.4.6. Integra LifeSciences
    • 8.4.6.1. Participant's Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Recent Developments/ Strategic Initiatives
  • 8.4.7. Ethicon (Johnson & Johnson)
    • 8.4.7.1. Participant's Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Recent Developments/ Strategic Initiatives
  • 8.4.8. Baxter
    • 8.4.8.1. Participant's Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Recent Developments/ Strategic Initiatives
  • 8.4.9. Molnlycke Health Care AB
    • 8.4.9.1. Participant's Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Recent Developments/ Strategic Initiatives

관련자료